Source Feed: Global News - Canada
Author: Adriana Fallico
Publication Date: April 2, 2026 - 14:38
Stay informed
Unpublished Opinions
Common antidepressant may help adults with long COVID: study
April 2, 2026
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
Unpublished Newswire
Jeff Groot, executive director of communications at BC Ferries, told Global News that it is unfortunate that the family had the situation they did.
April 10, 2026 - 22:01 | Amy Judd | Global News - Canada
April 10, 2026 - 21:51 | Patrick White | The Globe and Mail
April 10, 2026 - 21:15 | Matthew Scace | The Globe and Mail
Comments
Be the first to comment